Approval · Notice of Compliance 32648 · 2024
SELEXID: Notice of Compliance 32648
Issued February 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32648
- Date
- February 1, 2024
- Company
- Karo Healthcare AbStockholm, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- PIVMECILLINAM HCL 200 MG per TAB
- PIVMECILLINAM HCL 400 MG per TAB